Gates-backed COVID-19 antiviral spray moves toward clinic
To view this email as a web page, click here

Today's Rundown

Featured Story

J&J taps tiny Bioasis for tech to cross blood-brain barrier

Johnson & Johnson has turned to Bioasis for help getting drugs across the blood-brain barrier (BBB). The deal grants J&J’s Janssen the chance to use a human transport protein to shuttle drug molecules across the barrier to targets in the brain.

read more

Top Stories

Surf's up: Startup stoked as Chris Garabedian fund funnels cash into ultra-rapid insulin program

Surf Bio’s polymer-based drug delivery platform has caught the eye of some storied VCs. Needing cash to fund development of an ultra-rapid insulin program based on the technology, Surf Bio has reeled in $16 million in a seed round co-led by Breakout Ventures and Perceptive Xontogeny Venture (PXV) Fund.

read more

SK advances Gates-backed COVID-19 antiviral spray toward clinic

SK bioscience is stepping up work on a nasal spray to prevent and treat COVID-19. With the Bill & Melinda Gates Foundation kicking in cash, the Korean biotech is preparing for initial process R&D for the production of the antiviral nasal spray.

read more

Aquestive's oral rival to EpiPen clears test on path to pivotal trial

Aquestive Therapeutics’ oral epinephrine film has cleared another hurdle on its path to a pivotal clinical trial, holding its own against the intramuscular injection incumbent in a study of healthy volunteers.

read more

J&J, Roche partner Halozyme buys Antares Pharma for $1B, beefing up drug delivery offerings

Halozyme is best known for its under-the-skin drug delivery platform, with partnerships with the likes of Johnson & Johnson, GlaxoSmithKline and Roche. The company is now buying into the auto-injector realm and setting out to cultivate an internal commercial team.

read more

Biotech's top 10 money raisers of 2021

2021 marked the second consecutive year of record-breaking private financing for biotechs, with more than $28 billion raised. The total haul is a 26% increase from 2020, and the stunning dollar amounts came even as the public market depreciated throughout the year. Here's our look at the 10 biotechs that raked in the largest VC investments.

read more

Resources

Research: Healthcare Has No Borders: The Role of Rescue Sites in Times of Global Calamity

More than 570 clinical trials in Ukraine have been disrupted. Unanticipated disruptions to medical testing and clinical trials impede progress toward new breakthroughs and new therapies that millions of patients around the world hang their hope on. What role do rescue sites play?

Infographic: United Cargo: Providing Comprehensive Solutions For the Most Critical Shipments

The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now.

Whitepaper: Oncology Market Outlook: Key Trends to Watch

What’s in store for the oncology market in 2022 and beyond? This paper looks at 5 trends driving the market.

Whitepaper: Uncovering the hidden value of quality in chemical supply

Learn how to position quality as a central component within your raw material sourcing strategies for the chemicals used throughout your workflows. Download the free whitepaper from Thermo Fisher Scientific.

eBook: EMEA Regulatory Roadblocks around Decentralized Trials

Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research.

Events